Navigation Links
BGI reports pig parasite's genomic sequence provides new clues for parasitic diseases research
Date:10/28/2011

This release is also available in Chinese on EurekAlert! Chinese.

Shenzhen, China -- An international team of researchers, led by the University of Melbourne and BGI, has sequenced the draft genome of Ascaris suum, a parasitic roundworm of pig. This collaborative study, published online in the international journal Nature, provides a comprehensive resource to the scientific community and paves the way for the development of new and urgently needed interventions (drugs, vaccines and diagnostic tests) against ascariasis and other nematodiases.

Ascaris worms are soil-transmitted helminths causing ascariasis in human and animals. Human infections are commonly found in developing countries in Asia, Africa and Latin America, and favorably occurred in the tropical and sub-tropical areas with poor sanitation. Each year, more than one billion people worldwide are infected and about 135,000 are died for the diseases caused by these parasites. Parasite has been disasters to food animal producers due to the huge economic losses resulted from reduced growth and production loss of host animals.

In this study, researchers sequenced the A. suum genome at ~80-fold coverage and generated approximately 273 million base genome sequence for A. suum. The genome size is about 273 Mb and about 18,500 protein-coding genes were estimated. "Compare to the other metazoan genomes reported to date, we found this genome has few repetitive sequences, only about 4.4% of the total assembly." said Shiping Liu, the co-leading author of the study and Senior Bioinformatician of Comparative Genomics Group at BGI. "We later found out this phenomenon was probably caused by the chromatin diminution." he added.

Researchers had conducted the comparison of A. suum genome and sequences of other parasitic and free-living roundworms to understand the parasitism-related genetic factors of A. suum and its closely related species A. lumbricoides which causes human infections. In particular, many molecules and proteins identified have seemed to be involved in the invasion of host tissue and regulation with the host immune system. They predicted the secretome of A. suum to comprise 775 proteins with diverse functions and found the A. suum secretome (about 750 molecules) is rich in peptidases linked to the penetration and degradation of host tissues. Some members of the A. suum secretome may play an important role in host-tissue degradation and others are predicted to direct or evade immune responses.

"We also identified a number of potential drug targets. Notably, in the A. suum gene set, we found a homologue (acr-23) of the C. elegans monepantel receptor, suggesting that this drug may kill A. suum. By sequencing A. suum genome, we identified abundant key information to better understand the molecular biology of A. suum and the exquisite complexities of the hostparasite interactions on an immunobiological level. We believe our work will pave the way for the future Parasitic Diseases Research." said Liu.

"Each year, ascariasis affects billions of people and animals worldwide, so it is now crucial to understand its pathogenic mechanism by genomic and post-genomic approaches. In this study, we have more interesting findings, which can provide new hope for the discovery of intervention strategies, with major implications for improving global health." said Bo Li, the co-leading author of the study and Leader of Comparative Genomics Group.


'/>"/>
Contact: Jia Liu
liujia@genomics.cn
BGI Shenzhen
Source:Eurekalert

Related biology news :

1. Aware, Inc. Reports Third Quarter 2011 Financial Results
2. Extreme melting on Greenland ice sheet, reports CCNY team
3. Study reports predictors of poor hand hygiene in an emergency department
4. Reports highlight the evolving role of clinical microbiology laboratories
5. ReportsnReports - Biochips Market, Nuclear Medicine Market, Medical Imaging Market Research
6. Aware, Inc. Reports Second Quarter 2011 Financial Results
7. GEN reports on nanotechologys impact on mass spectrometry
8. Announcing Cell Reports -- a new open-access journal from Cell Press
9. Aware, Inc. Reports Second Quarter 2011 Financial Results
10. For the first time, the European IVF Monitoring Group reports on cycles using frozen eggs
11. Mary Ann Liebert Inc. publishers reports upward trend in impact factors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... 25, 2017  Securus Technologies, a leading provider ... public safety, investigation, corrections and monitoring, announces the ... "Too often, too many offenders return ... jails are trying to tackle this ongoing problem ... and family members. While significant steps are underway, Securus ...
(Date:2/21/2017)... 2017 Der weltweite Biobanking-Sektor wird ... einem Gespräch mit mehr als 50 Vertretern aus verschiedenen Branchen ... gilt, um diese Prognose zu realisieren. ... Zu den ... finanziellen Mittel für die Biobank, die Implementierung Zeit sparender ...
(Date:2/13/2017)... Former 9/11 Commission border counsel and Special Counsel to ... of Identity Strategy Partners, LLP, today releases the following ... Protecting the Nation From Foreign Terrorist Entry Into the ... Trump,s ,Travel Ban, Executive Order gains more notoriety and ... ban, it is important that our national discourse regain ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... March 23, 2017 According to a report ... derivatives market is fragmented due to the presence of a large pool ... Thermo Fisher , and Sigma-Aldrich, compete with each other in ... collectively, held more than 76% of this market in 2016.  ... As of now, a ...
(Date:3/23/2017)... New Orleans, La. (PRWEB) , ... March 23, ... ... of real-time, industrial monitoring solutions, today announced the hire of Dr. Sigmund “Sig” ... for APMT customer applications, strategic partnerships and joint development activities. , “Dr. Floyd’s ...
(Date:3/22/2017)...  Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical ... address significant unmet medical needs in rare diseases, ... ended December 31, 2016. "2016 ... we broadened our pipeline and pursued our vision ... with an initial focus on endocrinology," said ...
(Date:3/22/2017)... , March 22, 2017 Oramed ... ( www.oramed.com ), a ... oral drug delivery systems, announced today that Dr. ... will deliver a presentation titled, "Oral Insulin for ... Cambridge Healthtech Institute,s Oligonucleotide and Peptide Therapeutics (OPT) ...
Breaking Biology Technology: